key: cord-0805840-8aezcyf9
authors: Wen, Wen; Su, Wenru; Tang, Hao; Le, Wenqing; Zhang, Xiaopeng; Zheng, Yingfeng; Liu, XiuXing; Xie, Lihui; Li, Jianmin; Ye, Jinguo; Cui, Xiuliang; Miao, Yushan; Wang, Depeng; Dong, Jiantao; Xiao, Chuan-Le; Chen, Wei; Wang, Hongyang
title: Immune Cell Profiling of COVID-19 Patients in the Recovery Stage by Single-Cell Sequencing
date: 2020-03-27
journal: nan
DOI: 10.1101/2020.03.23.20039362
sha: 8c27de904a8b18419ec9e5b882a90d0b72838f4a
doc_id: 805840
cord_uid: 8aezcyf9

COVID-19 caused by SARS-CoV-2 has recently affected over 200,000 people and killed more than 8000. Immune system dysregulation such as lymphopenia and inflammatory cytokine storm has been observed in COVID-19 patients, but it remains unclear for the change of key immune cell subsets and their states during COVID-19. Here, we applied single-cell technology to comprehensively characterize transcriptional changes of peripheral blood mononuclear cells in ten patients recovered from COVID-19. Compared with healthy control, COVID-19 induced a unique signature of immune cells in humans, especially in the early recovery stage (ERS). In ERS patients, T cells were decreased remarkably, while monocytes were increased. A detailed analysis of monocytes showed that there was an increased ratio of classical CD14++ monocytes with highly inflammatory genes expression, as well as a greater abundance of CD14++IL1B+ monocytes. For nature killer (NK) cells and T cells, CD4+ T cells were significantly decreased and expressed high level of inflammatory markers, while NK cells were increased. In addition, T cells were highly expanded clone, especially in CD4+ T memory cells and CD8+ T cells. Among B cells, plasma cells were increased remarkably, and naïve B cells were reduced. Our study also identified several novel B cell receptor (BCR) changes (such as IGHV1-8 and IGHV3-7), and confirmed isotypes (IGKV3-11 and IGHV3-21) previously used for virus vaccine development. The strongest pairing frequencies, IGHV3-23+IGHJ4, indicated a monoclonal state associated with SARS-CoV-2 specificity. Furthermore, integrated analysis predicated that IL-1B and M-CSF may be novel candidate target gene for inflammatory storm, and TNFSF13, IL-18 and IL-4 may be benefit for the recovery of COVID-19 patients. Our study provides the first evidence of inflammatory immune signature in early recovery stage, suggesting that the COVID-19 patients are still vulnerable after hospital discharge. Our identification of novel BCR signaling may lead to the development of vaccine and antibodies for the treatment of COVID-19.

-The immune response sustains more than 7 days in early recovery stage of COVID-19, suggesting that the COVID-19 patients are still vulnerable after hospital discharge.

-Single cell analysis revealed immune cells interaction characterized by increasing of a subset of CD14 ++ IL1β + monocytes in ERS of COVID-19 patients.

-Newly identified virus specific BCR changes would be helpful for the development of vaccine and antibodies against SARS-CoV-2.

-IL-1β and M-CSF were discovered as novel mediators for inflammatory cytokine storm, and might be potential candidate targets in COVID-19 treatment.

-TNFSF13, TNFSF13B and IL4, IL18 were discovered as novel mediators for recovery mechanisms.

All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in Introduction COVID-19 caused by a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread in many countries [1] [2] [3] . As of 21 March 2020, SARS-CoV-2 has affected over 300,000 people and killed more than 10,000 of those affected in >160 countries. Following its global spread, it has been declared a public health emergency of international concern (PHEIC) by the WHO [4] . COVID- 19 show symptoms of fever, dry cough, fatigue, diarrhea, conjunctivitis, and pneumonia. Some patients developed severe pneumonia, acute respiratory distress syndrome (ARDS) or multiple organ failure [5] [6] [7] . Although scientists and clinicians globally made a great effort to produce vaccines and explore antiviral drugs [8, 9] , there remains no specific medicine and effective clinical treatment for COVID-19 [10, 11] .

Immune system dysregulation, such as lymphopenia and inflammatory cytokine storm are observed and are believed to be associated with disease severities of pathogenic coronavirus infections, such as the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV) infections [12, 13] . n COVID-19, recent studies also found decreases in lymphocytes number and increases in serum inflammatory cytokine levels in peripheral blood [5, 14] . However, it has remained largely unclear for the change of key immune cell subsets and their states during COVID-19. Defining key cellular subsets and their states in COVID-19 is a critical step in bringing critical insights into the immune clearance mechanism and new therapeutic strategy for COVID-19.

Here, we applied single-cell RNA sequence (scRNA-seq) to comprehensively characterize the changes of peripheral blood mononuclear cells from ten of COVID-19 patients. Our study depicts a highresolution transcriptome landscape of blood immune subsets in the recovery stage of COVID-19. It reveals that compared to healthy controls (HCs), monocytes contained highly inflammatory and IL1β + subset were predominated, while CD4 + T cells were decreased remarkably in the early recovery stage of COVID-19 patients. We found that T cells and B cells were highly expanded clone in recovery stage of COVID-19 patients. Furthermore, several specific BCR changes of COVID-19 patients in recovery stage may be helpful for vaccine and antibody production.

To map the immune microenvironment of the COVID-19 patients, identify mirroring changes in blood and pinpoint cell-specific alterations associated with the severity of the disease, we integrated singlecell RNA sequencing (scRNA-seq), single-cell paired BCR and single-cell paired TCR analysis from a total of ten of COVID-19 patients in early recovery stage (ERS) or later recovery stage (LRS) (70,858 cells). We also collected scRNA-seq data (57,238 cells) of five normal peripheral blood mononuclear cells (PBMCs) as controls ( Fig. 1A and Fig. S1 ). This dataset passed stringent high-quality filtering.

The single-cell suspensions of scRNA-seq samples were converted to barcoded scRNA-seq libraries using 10X Genomics. The CellRanger software (version 3.1.0) was used for initial processing of the sequencing data.

Using t-Distributed Stochastic Neighbor Embedding (t-SNE), we analyzed the distribution of the three immune cell lineages of myeloid cells, NK&T cells and B cells based on the expression of canonical lineage markers and other genes specifically upregulated in each cluster (Fig. 1B, C) . For marker genes, expression values in each cell positioned in a t-SNE are shown in Fig. 1D . We next clustered the cells of each lineage separately, and identified a total of 20 immune cell clusters.

The immune cell compartment of patients recovered from COVID-19 infection comprised all major immune lineages. We analyzed 128,096 scRNA-seq profiles passing quality control, including 36,442 myeloid cells, 64,247 NK&T cells and 10,177 B cells from five HCs, five ERS and five LRS patients.

The sketchy clustering analysis landscape of each subject is present in Fig. S2A and the merge picture of each group is shown in Fig. 2A . We discovered that COVID-19 patients including ERS and LRS demonstrate a higher proportion of myeloid cells compared to HCs, but with a lower proportion of NK&T cells (Fig. 2B, C) . Interestingly, LRS patients contained more B cells and NK&T cells, but less myeloid cells compared to ERS patients (Fig. 2B, C) . Thus, these findings indicated that COVID patients had decreased count of lymphocytes and increased count of myeloid cells in peripheral blood.

To further understand the changes of myeloid cells, NK&T cells and B cells in COVID-19 patients, we conducted difference expression gene (DEG) analysis of NK&T cells, B cells and myeloid cells All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted March 27, 2020. . https://doi.org/10.1101/2020.03. 23.20039362 doi: medRxiv preprint between HCs and patients. The Heat Map is shown in Fig. 2D -F. Inflammatory cytokines and   chemokines such as IL1B, CCL3, IRF1, DUSP1, JUN, FOS, etc. were all expressed at obviously high levels in patients regardless of myeloid cells (Fig. 2D ), NK&T cells (Fig. 2E) or B cells (Fig. 2F) .

Together, our results demonstrated that myeloid cells increased and NK&T cells decreased in the peripheral blood of COVID-19 patients, and that immune cell compositions differed between ERS and LRS patients.

To further understand the changes of monocytes in early and later recovery stage of COVID-19 patients, we conducted gene expression analysis and sub-clustered myeloid cells into six transcriptionally distinct subsets. Classical CD14 ++ monocytes (M1), non-classical CD16 ++ (FCGR3A) CD14 -/+ monocytes (M2), intermediate CD14 ++ CD16 + monocytes (M3), CD1C + cDC2 (M4) or CLEC9A + cDC1(M5) and pDC (CLEC4C + CD123 + ) (M6) were present in the six distinct clusters by UMAP (Fig.   3A ,B and S). We found that the compartment of the monocyte subset differed remarkably among HCs and COVID-19 patients (Fig. 3C ). Among myeloid cells, the ratio of classical CD14 ++ monocyte (M1) was increased in ERS patients compared with HCs, and was almost normal in the LRS patients ( Fig.   3C ).

We then found that COVID-19 patients have a greater abundance of CD14 ++ IL1β + monocytes and IFN-activated monocytes than HCs ( Fig. 3D-F ). Genes associated with CD14 ++ inflammatory monocytes (M1), have high expression levels of inflammatory genes such as IL1β, JUN, FOS, JUNB, KLF6, and chemokines, CCL4, CXCR4, and interferon stimulated genes IFRD1, IRF1, IFI6. In contrast, anti-inflammatory genes associated with CD14 ++ monocytes (M1) were downregulated in COVID patients relative to HCs (Fig. 3D, E) . Notably, IL1β expression values showed in a UMAP with simultaneous contrast indicated that IL1β was upregulated in ERS group, and decreased in LRS patients (Fig. 3F ). This was confirmed in DC cluster of ERS group compared to HCs (Fig. S3A-B ).

Next, we took the average of inflammatory genes for each myeloid cell scRNA-seq subset in the COVID-19 patients versus HCs (Fig. S3C) . These results demonstrate that cytokine activation drives expansion of monocyte populations (especially the CD14 ++ inflammatory monocytes) in COVIDinfected patients. To explore the biological significances of transcriptional changes in the M1 cluster, we performed GO analysis with DEGs (Fig. 3G) . We found enrichment of pathways, regarding All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted March 27, 2020. . cytokine signaling and inflammation activation, which were driven by the upregulation of IFITM3 and IFI6, and IL1β, JUN, FOS, JUNB, KLF6 (Fig. 3G ).

Together, these findings demonstrate that a dysregulated balance of monocyte populations in ERS patients, manifested by substantially increased classical CD14 ++ monocytes. Our results suggested that the classical CD14 ++ monocytes are increased in circulation to fuel the inflammation during SARS-

T and NK cell played critical roles in viral clearance during respiratory infections [15, 16] . Our clustering analysis sub-grouped T and NK lymphocytes into ten subsets ( The composition of the T and NK cells subset differed significantly among HCs and COVID-19 patients (Fig. 4C ). The ratio of CD8 + T cells was decreased in ERS COVID-19 patients, whereas the ratio of NK cells was increased compared with HCs. The ratio of CD4 + T cells was stable, but the composition of the CD4 + T cells subset differed significantly between HCs and COVID-19 patients.

Among CD4 + T cells, central memory CD4 + T cells was significantly increased, whereas the ratio of naïve CD4 + T cells was reduced compared with HCs. Notably, genes associated with CD4 + T cell, had relatively high expression levels of inflammation-related genes, and were significantly upregulated in COVID patients (Fig. 4D ). CD4 + T cells had high expression levels of inflammatory genes including All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted March 27, 2020. . https://doi.org/10.1101/2020.03. 23.20039362 doi: medRxiv preprint FOS, JUN, KLF6, S100A8 in ERS of COVID patients. (Fig. 4E ). In contrast, anti-inflammatory genes associated with CD4 + T cells were downregulated in COVID patients relative to HCs (Fig. 4D , E).

in the CD4 + T cells revealed enrichment of genes participating in cytokine pathway and inflammation activation, including IFITM3 and IFI6, and IL1B, JUN, FOS, JUNB, KLF6 (Fig. 4F ). Further studies are needed to elucidate IFN pathways in COVID pathogenesis.

TCR-seq analysis found that T cells expansion were obviously decreased in ERS group than HCs (Fig.   4G ). Moreover, naïve or central memory T cells showed little clonal expansion, while effector memory T cells, terminal effector CD8 + T cells (CTLs) and proliferating T cells showed the higher expansion levels ( Fig. 4H ). In addition, the most highly expanded (maximum) clone in ERS group was TRAV8-6-TRAJ45:TRAV7-8-TRBJ2-1 (Fig. S5D ). The decreased ratio of CD8 + T cells in COVID-19 patients may implicate a role of CD8 + T cells in the virus clearance (Fig. 4C ). The expanded clones might demonstrate potential over-activated inflammation in CTLs (Fig. 4I ). Together, these findings show that clonally expanded CD8 + T cells in peripheral blood of COVID-19 patients, which help to control the virus. We also performed DEGs analysis obtained via unsupervised clustering analysis and found similar results in Pro-T cells ( Fig. S4B -C). Next, we took the average of inflammatory genes for each NK&T cells subsets scRNA-seq subset in the COVID-19 patients versus normal RNA-seq data (Fig.   S4D ). In comparison with HCs, the percentage of plasma cells were significantly increased in COVID-19 patients, whereas naive B cells were significantly decreased in COVID-19 patients (Fig. 5C ). Memory

developing adoptive immunity as they synergistically worked and induced specific antibodies. All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in Moreover, compared to HCs, higher expression of B-cells-activation-related genes including CD27, CD86, XBP1 and MZB1 were primarily expressed in MPB of early stage of COVID patients (Fig. 5D) .

We also found similar results in plasma cells, the antibodies secreting cells (ASC) (Fig. S5B-C were over-presented in MPBs, which suggest enhanced B cell proliferation and viral transcription in COVID patients (Fig. 5F ). Single-cell BCR-seq analysis indicated that IgA isotype was overrepresented in COVID-19 compared to the HC (Fig. 5G ). This corresponded with an increase in the levels of serum IgA (Fig S5) , which was also pronounced in other coronavirus infection. Moreover, the ratio of (IgA+IgG+IgE)/(IgD+IgM) was significantly increased in ESR patients, and showed a downward trend with recovery time (Fig. 5H ).

Using sc-BCR-seq to assess the status of clonal expansions in the blood of patients, We found that IL4R + naïve B cells showed little clonal expansion, while CD27 + CD38 + memory B cells showed the highest expansion levels among diverse B cell subsets (Fig. 6A) . Next, at the individual levels, we found that COVID-19 patients had significantly expanded clones compared to HCs, supporting that B cells had experienced unique clonal VDJ rearrangements under the SARS-CoV-2 infection. We also found that a higher B cell clonality was consistently remained in ESR as compared with LSR patients (Fig. 6B) . Moreover, quantification of the most highly expanded (maximum) clone for each subject found that the ratios of the maximum clone were higher in ERS group than in HCs (Fig. 6C) . To understand the functional status of expanded cloned B cells, we performed DEG analysis between cloned memory B cells (N≥3) versus non-cloned cells. Our results showed increased expression of B cells genes including CD27, CD38, MZB1, XBP1 etc., which further supports a superior effector functions of those expanded cloned B cells (Fig. 6D) . Moreover, the differential genes for expanded B cells were significantly subsided over time and reduced in LRS patients.

In order to study the unique changes and preference genes of BCR in COVID-19 patients, we compared All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted March 27, 2020. . https://doi.org/10.1101/2020.03. 23.20039362 doi: medRxiv preprint the usage of VDJ genes in patients with HCs. We identified an over-representation of IGHV1-8, IGHV3-7, IGHV3-21, IGHV3-23 and IGHV3-49 in COVID-19 compared to HCs (Fig. 6E) . The preferred IGLV was IGKV1-17, IGKV2-28 and IGKV3-15. The preferred IGKV was IGLV1-44, IGLV2-8 and IGLV3-27 (Fig. 6E) . Moreover, the top two pairing frequencies in ERS patient were IGHV3-23-IGHJ4 and IGHV3-7-IGHJ6 (Fig. 6F) ; these cells showed IGH subunit pairing with the IGL/V subunit encoded by IGLV1-44-IGLJ3 and IGKV1-17-IGKJ1, respectively, which indicated expanded states associated with SARS-CoV-2 specificity. Individually, ERS-4 and ERS-5 had the maximum clone referring to IGHV3-23-IGHJ4 (Fig. S5E ) and IGHV3-7-IGHJ6 (Fig. S5F) , respectively.

In summary, an increase in clonality in COVID-19 that was dominated by the IgA and IgM isotypes, together with a skewed use of the IGHV gene, suggested the contribution of SARS-CoV-2 to pathogenesis. Notably, respiratory syncytial virus fusion glycoprotein-binding antibodies isolated from infants' blood utilized IGHV3-21 predominantly and displayed potent neutralizing activity. Given these results above, the biased usage of dominated IGVs genes, especially the IGHV3-23 and IGHV3-7 in COVID-19 patients, provides a framework for the rational design of SARS-CoV-2 vaccines.

An established computational approach [17] was to predict cell-to-cell interactions that may contribute to the distinct functional state of T cells, B cells, monocytes and DCs in ERS and LRS (Fig. 7A, B) .

In ERS COVID-19 patients, we found adaptive signals involved in monocytes activation, proliferation, and inflammatory signaling (Fig. 7A, B) . T cell expressed genes encoding for ligands of TNFSF8, LTA, IFNG, IL17A, CCR5 and LTB to TNFRSF8, TNFRSF1A/TNFRSF14, IFNGR1, IL-17RA, CCR1 and LTBR, which was expressed on monocytes and could contribute to the pro-inflammatory status. Other T cell-monocyte interactions involving the expression of CSF2 and CSF1. T cells might activate monocytes through the expression of CSF2 and CSF1 that bind to CSFRs (CSFR2/1) and contribute to inflammatory storm. A CD14 + monocytes cluster exclusively expressed IL1β, which was predicted to bind to IL1RAP expressed by T cells. T cell-monocyte interaction may enhance immune response and be exclusive deteriorate to COVID-19 patients. (Fig. 7A, B) . Furthermore, we found monocyte highly expressed poliovirus receptor (PVR) which serves as a cellular receptor for poliovirus in the first step of poliovirus replication and inducing NF-kappa B signaling pathway. From B cell-monocyte All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in and B cell-T cell interaction, we found B cell could secret a large number of IL-6, LTA and LTB which combined to IL-6R, LTAR and LTBR expressed in monocytes, and a large number of IL-6 apply to T cells to promoted the secretion of IFN-γ, IL-1β and other inflammatory cytokines and chemokines.

Thus, a cascade signature of inflammatory monocytes with high expression of IL-6 and their progeny were formed in the peak incidence of ERS COVID-19 patients (Fig. 7C) . These activated immune cells may enter the circulation of lung and other organs in large numbers and played an immune damaging role. In LRS COVID patients, DC ligands were predicted to interact with B cell and T cell receptors involved in cell proliferation and the produce of antibodies. We discovered that the peripheral blood of LRS patients contain a diversity abundance of antibodies, and we found that IL18−IL18RAP, TNFSF13-TNFRSF13B, TNFSF13-TNFRSF17, TNFSF13B−TNFRSF17, TNFSF13B−TNFRSF13B and TNFSF13B−TNFRSF13C were highly expressed in our analysis of DC-B cell interaction (Fig.   7D ). Thus, we speculate that DC produce IL-18, TNFSF13 and TNFSF13B to promote the proliferation of B cell and then secret many antibodies into blood in ERS. From DC-T cell and T cell-B cell interaction, we discovered that DC not only produces IL-18 but also IL-7, to promote the proliferation of T cells, and T cells produce IL-2 to promote the proliferation of B cell and produce antibodies (Fig.   7D ).Thus, cell-to-cell interactions help us to understand why COVID-19 patients manifested high rates of monocytes and low rates of lymphocytes and the proportion of lymphocyte gradually increased in recovery patients in peripheral blood.

All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in 

The clinical presentation of COVID-19 varies from asymptomatic to severe ARDS. This has been similarly observed in severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV) and influenza infections [12, 14] . In viral infection, it is generally accepted that host immune responses determine both the protection against viral infections and pathogenesis of respiratory injury [18, 19] . A coordinated response in innate and adaptive immune cells working in concert may lead to a rapid control of virus, while a failed immune response might lead to viral spreading, cytokine storm, and a high mortality rate [20] . Despite being the same group of viruses, recent studies have highlighted differences between COVID-19, SARS, and MERS, such as the speed of transmission, treatment scheme and mortality rate. Moreover, the difference may also exist in the key immune players and the underlying molecular mechanisms related to these diseases.

The lack of knowledge regarding the immune impact of COVID-19 has now become a critical issue in view of its fast spread and the shortage of specific therapy [21] . U Using single-cell sequencing, we profile the complexity of immune populations in blood and analyzed 70,858 cells from 10 patients. We identify a hyper-inflammation response in ERS patients, which may explain why some patients fell sick after being discharged, and suggest that the current criteria for hospital release should be reevaluated. In addition, we identify unique signatures of myeloid, NK, T and, B cells, and pinpoint the changes in epitopes of TCR and BCR. Our findings help elucidate the antiviral immune mechanisms and reveal promising opportunities in developing immunotherapies using vaccines and neutralizing antibodies.

Inflammation is a vital part of the immune system's response to COVID-19 invasion, as previous and latest studies have reported significantly higher levels of inflammatory cytokines associated with disease severity in SARS, MERS and COVID-19 patients [22, 23] . Among the various inflammatory cells, monocytes and their subsets (including classical, intermediate and non-classical monocytes) may play a critical effect because they are known to fuel inflammation [24] [25] [26] [27] . In our study, compared with healthy controls, ERS patients demonstrate a significantly higher ratio of monocytes, and these cells express higher levels of inflammatory genes. Intriguingly, the ratio of classical CD14 + monocytes is high in ERS but returns normal in LRS. Furthermore, CD14 + IL1β monocytes, which are absent in healthy controls, could be observed in ERS and they decline in LRS. Notably, our cell-to-cell interaction analysis indicated that IL1β, CSF1, IL6, and CSF2 may be associated with cytokine storm. Taken All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted March 27, 2020. . https://doi.org/10.1101/2020.03. 23.20039362 doi: medRxiv preprint together, our data provide important insight into the roles of monocytes in the immunopathogenesis of COVID-19.

Adaptive immune system harbors the ability to recognize and remember specific pathogens through antibody and T cell responses [28] . Inducing adaptive immunity is the aim of vaccination [29] . Previous SARS studies have identified binding and neutralizing antibodies elicited by SARS-CoV infection.

Their therapeutic effect is unclear [30] , although robust antibody responses could be induced [31] . In antibody to neutralize human cytomegalovirus [32, 33] . In addition, IGHV3-30 and IGHV3-21 have been utilized to isolate influenza virus antibodies and used for the production of virus vaccine [34, 35] .

Moreover, recent study demonstrated that antibodies combining the IGHV3-15/IGLV1-40 segments had superior activities neutralizing to Zaire Ebola virus [36] . Besides, we observed a decrease in the expression of inflammatory gene is ERS patients compared with HCs. We envision that our results will provide a direction for the future development of vaccine and antibodies of COVID-19 patients.

Interaction between immune cells may help to expedite or defer recovery from COVID-19 infection.

Our cell to cell prediction analysis utilizing scRNA-seq data indicated that, in ERS patients, B cellderived IL-6 and T cells-derived CSF1(M-CSF) and CSF2(GM-CSF) may promote monocyte proliferation and activation. As a result, monocytes may produce a larger number of inflammatory mediators including IL-1β and IL-6, contributing to inflammatory storm. In LRS patients, both DCs-All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted March 27, 2020. . https://doi.org/10.1101/2020.03. 23.20039362 doi: medRxiv preprint derived TNFSF13 and IL-18, and T cells-derived IL-2, may promote B cells survival, proliferation and differentiation. Consequently, B cells produce numerous SARS-COV2 specify antibodies to clear virus.

In conclusion, our study provides the first immune atlas of patients recovered from COVID-19 and identifies adaptive immune dysregulation after discharge. The clone expansion of both T cell and B cell indicates that the body immune system is gradually recovered, but the hyper-inflammatory response sustaining more than 7 days after discharge suggests the need for medical observation after patient release from hospital. Longitudinal studies of recovered patients on a larger cohort might help to understand the consequences of the disease. The novel BCRs identified in our study may advance our understanding of B cell mechanisms and have potential clinical utility in COVID-19

immunotherapies.

All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted March 27, 2020. . https://doi.org/10.1101/2020.03. 23.20039362 doi: medRxiv preprint patients or healthy donors using a Ficoll-Hypaque density solution according to standard density gradient centrifugation methods. For each sample, the cell viability exceeded 80%.

The single-cell suspensions of scRNA-seq samples were converted to barcoded scRNA-seq libraries using the Chromium Single Cell 5′ Library, Gel Bead and Multiplex Kit, and Chip Kit (10X Genomics).

The Chromium Single Cell 5′ v2 Reagent (10X Genomics, 120237) kit was used to prepare single-cell RNA libraries according to the manufacturer's instructions. The FastQC software was used for quality check. The CellRanger software (version 3.1.0) was used for initial processing of the sequencing data.

We de-multiple and barcode the sample by using The Cell Ranger Software Suite (Version 3.1.0) and with command cellranger count. After getting each sample gene counts, and aggregate them together.

Finally, gene-barcode matrix of all ten patients and five HCs was integrated with Seurat v3 and monocle3. Following criteria were then applied to each cell, i.e., gene number between 200 and 7000. 

We handle the data with Log normalize before cluster and reduction, scale data with top 5000 most 

Seurat v3 and Monocle 3 was used to perform differential analysis. For each cluster, differentiallyexpressed genes (DEGs) were generated relative to all of the other cells.

For DEGs, Gene ontology (GO), KEGG pathway analyses were performed using Metascape webtool (www.metascape.org).

All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in Using barcode information, T/B cells with prevalent TCR/BCR clonotypes were projected on a t-SNE plot.

The cell-cell interaction analysis was based on the expression of immune-related receptors and ligands.

The gene list contained 135 pairs of well-annotated receptors and ligands, including cytokines, chemokines and co-stimulators. We estimated the potential interaction between two cell types mediated by a specific ligand-receptor pair by the product of the average expression levels of the ligand in one cell type and the corresponding receptor in the other cell type.

All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in 

A Novel Coronavirus from Patients with Pneumonia in China

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia

Coronavirus Disease 2019 (COVID-19) in Italy

Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating personto-person transmission: a study of a family cluster

Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore

This scientist hopes to test coronavirus drugs on animals in locked-down Wuhan

In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Critical care management of adults with community-acquired severe respiratory viral infection

A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19

Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study

SARS and other coronaviruses as causes of pneumonia

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China

Airway Memory CD4(+) T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses

Severe pandemic H1N1 2009 infection is associated with transient NK and T deficiency and aberrant CD8 responses

Analysis of Single-Cell RNA-Seq Identifies Cell-Cell Communication Associated with Tumor Characteristics

Immunopathogenesis of coronavirus infections: implications for SARS

Species-Specific Host-Virus Interactions: Implications for Viral Host Range and Virulence

Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8⁺ T cells

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology

Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV

Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice

Multiple organ infection and the pathogenesis of SARS

Lung pathology of fatal severe acute respiratory syndrome

Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors

Adaptive immunity

Innate and adaptive immune responses to viral infection and vaccination

Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals

Recovery from the Middle East respiratory syndrome is associated with antibody and T-cell responses

Germline V-genes sculpt the binding site of a family of antibodies neutralizing human cytomegalovirus

Somatic diversity in CDR3 loops allows single V-genes to encode innate immunological memories for multiple pathogens

A broadly neutralizing anti-influenza antibody reveals ongoing capacity of haemagglutininspecific memory B cells to evolve

Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic Hypermutation. Immunity

Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV

Comprehensive Integration of Single-Cell Data

The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells

Metascape provides a biologist-oriented resource for the analysis of systems-level datasets